Coriell Institute and NIH Provide Scientists with Powerful New Stem Cells
Press Release | June 27, 2011
CAMDEN, N.J. – Coriell Institute for Medical Research announced today the availability of powerful new stem cells to the scientific research community. These cells – called induced pluripotent stem cells – possess many of the important properties of embryonic stem cells. However, they bypass controversy as they can be made from skin cells or blood cells, avoiding the need to involve embryo-derived cells. Induced pluripotent stem (iPS) cells can multiply indefinitely and can become almost any type of cell in the human body. These cell lines, available through the National Institutes of General Medical Sciences (NIGMS) Human Genetic Cell Repository at Coriell, were derived from individuals with Huntington’s disease, juvenile onset diabetes, muscular dystrophy, spinal muscular atrophy, or severe combined immunodeficiency.
The demand in the research community for access to iPS cells is quickly growing. Coriell’s President and CEO, Michael F. Christman, Ph.D., recognizes the importance of incorporating this new technology into Coriell’s repertoire. “The promise of stem cell research lies in its application in understanding the progression of human disease, to better target therapies to optimize our health outcomes, and to ultimately use stem cells therapeutically to cure disease and reverse injury,” says Christman.
Click HERE or on the image below to read more…